Stock Events

Stock Events

Mithra Pharmaceuticals SA 

$23.9
80
+$0+0% Tuesday 20:00

Statistics

Day High
6.75
Day Low
6.75
52W High
6.75
52W Low
6.75
Volume
3,549
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22SepExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q4 2021
Q2 2022
-0.83
-0.55
-0.28
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-474.16%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
52.08MRevenue
-246.92MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MITPF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Mithra in the women's health market, particularly in contraceptives and hormone therapy products.
Merck
MRK
Mkt Cap214.76B
Merck is involved in developing and marketing pharmaceuticals in various therapeutic areas, including women's health, directly competing with Mithra's product offerings.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk competes with Mithra in the hormone therapy space, particularly in treatments that overlap with Mithra's focus areas.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, including women's health products that compete with Mithra's portfolio.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the women's health sector, offering hormone therapy and other pharmaceuticals that compete with Mithra's products.
AMGEN
AMGN
Mkt Cap160.66B
Amgen focuses on human therapeutics, including treatments in areas that could compete with Mithra's hormone therapy products.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline has a diverse portfolio including women's health products that compete with Mithra Pharmaceuticals in certain markets.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, offers products in women's health, competing with Mithra in various therapeutic areas.

About

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.
Show more...
CEO
Mr. Christophe Marechal
Employees
270
Country
US

Listings

0 Comments

Share your thoughts

FAQ

What is Mithra Pharmaceuticals SA stock price today?▼
The current price of MITPF is $23.9 USD — it has increased by +0% in the past 24 hours. Watch Mithra Pharmaceuticals SA stock price performance more closely on the chart.
What is Mithra Pharmaceuticals SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mithra Pharmaceuticals SA stocks are traded under the ticker MITPF.
What is Mithra Pharmaceuticals SA revenue for the last year?▼
Mithra Pharmaceuticals SA revenue for the last year amounts to 52.08M USD.
What is Mithra Pharmaceuticals SA net income for the last year?▼
MITPF net income for the last year is -246.92M USD.
How many employees does Mithra Pharmaceuticals SA have?▼
As of April 01, 2026, the company has 270 employees.
In which sector is Mithra Pharmaceuticals SA located?▼
Mithra Pharmaceuticals SA operates in the Health Care sector.
When did Mithra Pharmaceuticals SA complete a stock split?▼
Mithra Pharmaceuticals SA has not had any recent stock splits.
Where is Mithra Pharmaceuticals SA headquartered?▼
Mithra Pharmaceuticals SA is headquartered in Liège, US.